Biohm Technologies
Afif Ghannoum is an accomplished executive with extensive experience in leadership and investment roles. Currently serving as Chief Executive Officer at CPG Radar since August 2024, Afif also holds the positions of Chairman and CEO at BIOHM Health since October 2016. As an investor, Afif has been involved with multiple companies, including Bawi Agua Fresca, Onda, Retextion, KINLÒ, and Sourse Inc., all since 2022. Additionally, Afif has a longstanding association with Oasis Ventures LLC, serving as Board Member and President, and as a Board Member for Next Trillion Sciences, a prominent antifungal CRO. Afif's previous role as Founder and CEO of Small Co. Capital lasted from January 2024 to August 2024. Afif holds a JD from Case Western Reserve University School of Law and a bachelor's degree from Case Western Reserve University.
This person is not in the org chart
This person is not in any teams
Biohm Technologies
Biohm Technologies, based in Cleveland, OH, specializes in the development of targeted microbiome products leveraging the company’s extensive dataset of bacterial and fungal populations in the gut, a departure from the industry's predominant focus on bacteria alone. Biohm’s data-driven methodology, called Symbiont™, is the basis for the creation of award-winning ingredients validated through clinical trials. The company’s flagship ingredient is Mycohsa™, the first data-powered probiotic blend clinically shown to break down digestive biofilms and support optimal levels of both bacteria and yeasts for gut health. Biohm Technologies also offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space.